I-STAT EC8+ CARTRIDGE
Report
- Report Number
- 2245578-2022-00150
- Event Type
- Malfunction
- Date Received
- October 27, 2022
- Date of Event
- October 11, 2022
- Report Date
- November 28, 2022
- Manufacturer
- ABBOTT POINT OF CARE
- Product Code
- CHL
- UDI-DI
- 10054749000071
- PMA / PMN Number
- K940918
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SW
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
APOC INCIDENT: # (B)(4). THE INVESTIGATION WAS COMPLETED ON 23-NOV-2022. A REVIEW OF THE DEVICE HISTORY RECORD (DHR) CONFIRMED THE CARTRIDGE LOT MET FINISHED GOODS RELEASE CRITERIA. RETAINED TESTING MET THE ACCEPTANCE CRITERIA FOUND IN Q04.01.003 REV. AK, APPENDIX 1 - PRODUCT COMPLAINT LEVEL 2 AND LEVEL 3 INVESTIGATION PROCEDURE. NO DEFICIENCY HAS BEEN DETERMINED FOR EC8+ CARTRIDGE LOT K22085.
APOC INCIDENT # (B)(4). APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.
ON (B)(6) 2022, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER REGARDING I-STAT EC8+ CARTRIDGES THAT YIELDED SUSPECTED DISCREPANT PCO2 RESULTS ON A MALE PATIENT WITH SEVERE ACIDOSIS. THERE WAS NO PATIENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT. DATE: (B)(6) 2022. TIME: 13:59 14:27. NA: 126 MMOL/L 125MMOL/L . K: 8.4 8.2 MMOL/L . CL: 100 MMOL/L 104 MMOL/L . TCO2 6 <5. UREA: 19.6 MMOL/L 19.5 MMOL/L. HCT: 42%PCV 38% PCV. PH: 6.772 6.833 . PCO2: 4.55 KPA 2.33 KPA. HCO3: 5.0 MMOL/L 2.9 MMOL/L. BEECF:-30 <-30 . ANGAP:30 MMOL/L <> . HB: 143 G/L 129 G/L . AT THIS TIME THERE IS NO REASON TO SUSPECT A MALFUNCTION EXISTS. THE REPORTING DECISION WAS BASED ON THE LIMITED INFORMATION AVAILABLE THAT SUGGESTS THE PRODUCT WAS NOT PERFORMING WITHIN THE VARIABILITY OF THE ASSAY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2557044 | I-STAT EC8+ CARTRIDGE | EC8+ CARTRIDGE | CHL | ABBOTT POINT OF CARE | NA | K22085 | 10054749000071 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Male |